We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
Cap. Flow
+$486M
Cap. Flow %
2.22%
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 10.43%
2 Financials 4.62%
3 Consumer Discretionary 4.22%
4 Healthcare 3.87%
5 Industrials 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHW
2251
Calamos Global Dynamic Income Fund
CHW
$553M
$426K ﹤0.01%
70,844
+2,172
+3% +$12.8K
RFDA icon
2252
ALPS Dynamic US Dividend Advantage ETF
RFDA
$90.6M
$426K ﹤0.01%
9,224
-6,608
-42% -$289K
SHLS icon
2253
Shoals Technologies Group
SHLS
$1.4B
$425K ﹤0.01%
16,625
-780
-4% -$18K
UBS icon
2254
UBS Group
UBS
$176B
$424K ﹤0.01%
20,925
-1,486
-7% -$29.9K
AYI icon
2255
Acuity Brands
AYI
$10.8B
$421K ﹤0.01%
2,581
+51
+2% +$8.14K
GBF icon
2256
iShares Government/Credit Bond ETF
GBF
$128M
$421K ﹤0.01%
4,044
+101
+3% +$10.6K
KNSL icon
2257
Kinsale Capital Group
KNSL
$8.51B
$421K ﹤0.01%
1,124
+142
+14% +$47.1K
PRI icon
2258
Primerica
PRI
$9.57B
$421K ﹤0.01%
2,128
-141
-6% -$25.9K
KORP icon
2259
American Century Diversified Corporate Bond ETF
KORP
$899M
$420K ﹤0.01%
9,209
+1,773
+24% +$81.5K
KRTX
2260
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$419K ﹤0.01%
1,930
-70
-4% -$15K
MTH icon
2261
Meritage Homes
MTH
$4.75B
$418K ﹤0.01%
5,876
-28,738
-83% -$1.8M
PATH icon
2262
UiPath
PATH
$8.64B
$418K ﹤0.01%
25,238
+6,614
+36% +$106K
H icon
2263
Hyatt Hotels
H
$16.8B
$417K ﹤0.01%
3,635
+467
+15% +$52.8K
GNMA icon
2264
iShares GNMA Bond ETF
GNMA
$433M
$416K ﹤0.01%
9,493
+24
+0.3% +$1.06K
KALU icon
2265
Kaiser Aluminum
KALU
$2.99B
$415K ﹤0.01%
5,795
NPV icon
2266
Nuveen Virginia Quality Municipal Income Fund
NPV
$215M
$415K ﹤0.01%
38,466
-5,972
-13% -$66K
REET icon
2267
iShares Global REIT ETF
REET
$5.08B
$415K ﹤0.01%
18,087
-8,174
-31% -$186K
VAMO icon
2268
Cambria Value and Momentum ETF
VAMO
$109M
$415K ﹤0.01%
16,118
+3,262
+25% +$80.7K
BNTX icon
2269
BioNTech
BNTX
$23.3B
$414K ﹤0.01%
3,832
+655
+21% +$73.7K
EAPR icon
2270
Innovator Emerging Markets Power Buffer ETF April
EAPR
$102M
$414K ﹤0.01%
16,825
+4,416
+36% +$108K
POWR
2271
iShares U.S. Power Infrastructure ETF
POWR
$464M
$414K ﹤0.01%
17,855
-3,625
-17% -$84.6K
VAC icon
2272
Marriott Vacations Worldwide
VAC
$4.1B
$414K ﹤0.01%
3,375
+33
+1% +$4.27K
EMNT icon
2273
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$217M
$413K ﹤0.01%
4,221
-447
-10% -$43.7K
FTV icon
2274
Fortive
FTV
$18.6B
$413K ﹤0.01%
7,324
+475
+7% +$24K
NEE.PRQ
2275
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
$413K ﹤0.01%
8,422
-153
-2% -$7.46K

Similar funds

Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
  • Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
  • Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.